期刊文献+

SYBR荧光实时定量PCR检测非小细胞肺癌组织与外周血中RRM1和ERCC1及BRCA1基因表达水平 被引量:8

Detection of RRM1,ERCC1 and BRCA1 gene expression in non-small cell lung cancer tissues and peripheral blood by SYBR real-time fluorescent quantitative PCR
在线阅读 下载PDF
导出
摘要 目的:建立荧光实时定量PCR技术,检测非小细胞肺癌组织与外周血RRM1和ERCC1及BRCA1基因表达水平。方法:分别构建RRM1、ERCC1和BRCA1及管家基因β-actin质粒标准品,以SYBR荧光实时定量PCR分析,制备标准曲线,对非小细胞肺癌组织与外周血中RRM1、ERCC1和BRCA1及管家基因β-actin的mRNA进行检测。结果:标准曲线呈良好的线性关系。标准品的熔解曲线均呈单峰,特异性良好,说明基本无非特异性扩增。结论:所建SYBR荧光实时定量PCR方法操作简便,费用低,特异性好,准确度、灵敏度高,为后续研究构建了理想的平台。 Objective: To develop a method for the detection of RRM1,ERCC1 and BRCA1 gene expression by SYBR real-time fluorescent quantitative PCR in non-small cell lung cancer tissues and peripheral blood.Methods: The plasmid standard of RRM1,ERCC1,BRCA1 and β-actin genes was constructed.SYBR real-time PCR was performed,and the standard curve was established.The expressions of RRM1,ERCC1 and BRCA1 mRNA in non-small cell lung cancer tissues and peripheral blood were detected.Results: The standard curve presented linearity.The liquate curves of standard gene were all single apex,indicating that a good specificity was obtained.Conclusion: The developed SYBR real-time fluorescent quantitative PCR has advantage of convenient operation,low cost,good specificity and high veracity.
出处 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2010年第6期628-633,共6页 Journal of Zhejiang University(Medical Sciences)
基金 浙江省科技计划资助项目(2009C33165) 浙江省医药卫生科学研究基金计划项目(2008A060)
关键词 SYBR 荧光实时定量 PCR检测 非小细胞 肺癌组织 外周血 RRM1 ERCC1 BRCA1基因 表达水平 Detection quantitative real-time peripheral blood lung cancer cell gene expression 特异性扩增 管家基因 标准曲线 Carcinoma,non-small-cell lung Polymerase chain reaction Nucleotides/genet Real-time fluorescent quantitative PCR Non-small cell lung cancer Gene expression RRM1 ERCC1 BRCA1
  • 相关文献

参考文献6

二级参考文献38

  • 1董嵩,吴一龙.RRM1基因表达水平预测肺癌对吉西他滨耐药性的研究进展[J].肿瘤研究与临床,2006,18(6):426-428. 被引量:7
  • 2ROSELL R,SCAGLIOTTI G,DANENBERG K D,et al.Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer[ J ].Oncogene,2003,22(23):3548-3553.
  • 3ROSELL R,CRINO L,DANENBERG K,et al.Targeted therapy in combination with gemcitabine in non-small cell lung cancer[J].Semin Oncol,2003,30(4 Suppl 10):19-25.
  • 4BEPLER G,SHARMA S,CANTOR A,et al.RRMI and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer[J].J Clin Oncol,2004,22(5):1878-1885.
  • 5ZHENG Z,CHEN T,LI X,et al.DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer[J].N Engl J Med,2007,356(8):800-808.
  • 6SMITH B D,KARP J E.Ribonucleotide reductase:an old target with new potential[J].Leuk Res,2003,27 (12):1075-1076.
  • 7ROSELL R,FELIP E,TARON M,et al.Gene expression as a predictive marker of outcome in stage Ⅲ B-Ⅲ A-Ⅲ B non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery[J].Clin Cancer Res,2004,10 (Suppl):4215-4219.
  • 8ROSELL R,DANENBERG K,SANCHEZ J J,et al.Ribonucleotide reductase M1 (RRM1) mRNA expression and survival in advanced non-small-cell lung cancer patients treated with gemcitabine plus cisplatin[ J ].Lung Cancer,2003,41 (Suppl 2):0-43.
  • 9FUKUOKA M,YANO S,GIACCONE G,et al.Multi-institutional randomized phase Ⅱ trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer[J].J Clin Oncol,2003,21 (12):2237-2246.
  • 10SCHILLER J H,HARRINGTON D,BELANI C P,et al.Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer[J].N Engl J Med,2002,346(2):92-98.

共引文献67

同被引文献50

  • 1SHARPE AH, WHERRY EJ, AHMED R, et al. The function of programmed cell death 1 and its ligands in regulating autoim- munity and infection[J]. Nat Immunol, 2007, 8(3): 239-245.
  • 2Chinese DONG H, STROME S, SALOMAO DR, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of im- mune evasion[J]. Nat Med, 2002, 8(8): 793-800.
  • 3KAMADA N, CALNE RY. A surgical experience with five hun- dred and thirty liver transplantation in the rat[J]. Surgery, 1983, 93(1): 64-69.
  • 4ANTHONY J, DEMETRI S, KENNETH P, et al. Banff schema for grading liver allograft rejection: an international consensus document[J]. Hepatol, 1997, 25: 658-663.
  • 5HOLETS LM, CARLETH MZ, KSHIRSAGAR SK, et al. Differ- entiation-induced posttranseriptional control of B7-H1 in human trophoblast cells[J]. Placenta, 2009, 30(1): 48-55.
  • 6MORITA M, FUJINO M, JIANG G, et al. PD-1/B7-H1 Inter- action Contribute to the Spont.aneous Acceptance of Mouse Liver allograft[J]. Am J Transplant, 2009, 10(1): 40-46.
  • 7KANTI P, SALLENE W, ANITA A, et al. Design and validation of real-time reverse transeription-PCR assays for detection of pandemic (H1N1) 2009 virus[J]. J Clin Microbiol, 2009, 47(11): 3454-3460.
  • 8JEMAL A, SIEGEL R, WARD E, et al. Cancer statistics 2009 [ J ]. CA Cancer J Clin, 2009,59 (4) :225-249.
  • 9GOSSAGE L, MADHUSUDAN S. Current status of excision repair cross complementing-group 1 (ERCC1) in cancer [ J ]. Cancer Treat Rev, 2007,33 (6) : 565-577.
  • 10OLAUSSEN K A, FOUTET P, KROEMER G. ERCCl-specific immunostaining in non-small-cell lung cancer [J]. N Engl J Meal,2007,357(15) : 1559- 1561.

引证文献8

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部